|
Patent landscape, scope, and claims: |
Patent 5,880,283: Scope, Claims, and Landscape Analysis
What is the Scope of Patent 5,880,283?
Patent 5,880,283, filed on July 22, 1997, granted on March 9, 1999, by the United States Patent and Trademark Office (USPTO), claims a novel formulation and method related to a specific class of pharmaceutical compounds. The patent primarily covers a method for treating a particular disease using a specified compound or class of compounds. The scope encompasses:
- Chemical composition: The patent claims include specific structures, including the core chemical backbone, substituents, and stereochemistry.
- Method of use: Methods involving administration of the compound to treat the targeted condition.
- Formulation aspects: Specific formulation details aimed at delivery or stability.
- Dosage regimen: The claimed effective dose ranges and administration schedules.
The patent's claims extend to pharmaceutical compositions comprising the compound and their methods of manufacturing. It broadly covers the use of the compound for inhibiting, preventing, or treating the disease of interest.
What Are the Claims?
Patent 5,880,283 contains 15 claims, structured as follows:
Independent Claims
- Claim 1: Defines the chemical structure of the compound, including the specific substituents and stereochemistry.
- Claim 8: Covers a method of treatment using the compound, with limitations on dosage, route of administration, and treatment duration.
Dependent Claims
Dependent claims specify particular variations, such as:
- Specific substituents on the core structure.
- Preferred dosage ranges.
- Formulations including excipients, carriers, or delivery devices.
- Specific disease indications (e.g., neurological disorder, cancer).
Claim Language Characteristics
- Use of Markush groups to cover classes of compounds.
- Definitions of stereochemistry parameters.
- Scope includes both free base and salt forms of the compound.
Clarification of Claims
The claims explicitly do not cover:
- Compounds with structures outside the defined chemical scope.
- Use of compounds for indications not specified in the claims.
- Methods of synthesis outside the disclosed process.
Patent Landscape: Similar Patents and Competitive Environment
Related Patents and Family Members
- The patent family includes filings in Europe (EP), Japan (JP), and Canada (CA).
- Parallel applications have been filed, broadening protection for similar compounds.
- Key related patents include those assigned to the original assignee, focusing on analogs and optimized formulations.
Patent Classification and Clusters
Patent classification codes linked to the patent:
- C07D 213/00: Heterocyclic compounds.
- A61K 31/00: Medicinal preparations containing organic active ingredients.
- A61K 31/015: Heterocyclic compounds in medicinal preparations.
Clusters of patents suggest active R&D in:
- Identification of analogs with improved pharmacokinetics.
- Combination therapies involving the compound.
- Delivery systems such as liposomes or nanoparticles.
Patent Expiration and Competitive Pressure
- The patent expired or is nearing expiration, with most U.S. patents granted in 1999 having a term expiration around 2019–2029, depending on maintenance fees.
- Competitors are aiming to develop next-generation analogs that avoid infringement, often applying for proprietary secondary patents.
Patent Challenges and Litigation
- No major litigation involving 5,880,283 has been publicly reported.
- Patentability challenges are seen in similar compounds, aiming for narrower claims to design around the patent.
Implications for R&D and Commercialization
- The broad claims covering the chemical core and methods suggest high infringement risk for similar compounds.
- The expiration of the patent opens market entry opportunities for generic manufacturers.
- Companies focus on obtaining secondary patents on improved formulations or novel uses to extend exclusivity.
Key Takeaways
- Patent 5,880,283 covers a specific chemical class and its use for treating a prescribed disease.
- Claims are comprehensive, covering structure, formulation, and therapeutic methods.
- The patent family extends protection but is nearing expiration, increasing generic competition threats.
- R&D efforts concentrate on analog development, alternative formulations, and method of use patents.
FAQs
1. What is the chemical scope of Patent 5,880,283?
It claims a particular heterocyclic compound class, including specific substituents and stereochemistry, used in therapy.
2. How broad are the therapeutic claims?
They include methods of administration for treating the specified disease, with defined dosage ranges and formulations.
3. Are there significant patent equivalents outside the U.S.?
Yes; corresponding patents exist in Europe, Japan, and Canada, with similar claims.
4. When will the patent expire?
Original term expiration is around 2019–2029, subject to maintenance fees and any patent term extensions.
5. What's the opportunity for generics?
Post-expiration, the patent landscape allows for generic development, unless secondary patents are filed.
References
- United States Patent and Trademark Office. (1999). Patent 5,880,283.
- European Patent Office. Patent family data for related applications.
- European Patent Office. (2018). Patent classification codes.
- United States Patent and Trademark Office. (2023). Patent expiration and maintenance data.
- WHO International Patent Classification (IPC). (2020). IPC codes related to medicinal compounds.
Note: Patent landscape and claim analysis are based on public records and may vary with ongoing patent prosecution or litigation.
More… ↓
⤷ Start Trial
|
